Gates Foundation Strategic Investment Fund Logo
Share this page:

Press Release: OraSure Technologies to Drive Accelerated Adoption of OraQuick® HIV Self-Test

Orasure Technologies, Inc.

June 27, 2017

OraSure Technologies, Inc., a leader in point-of-care diagnostic tests and specimen collection devices, today announced a new agreement with the Bill & Melinda Gates Foundation that will enable OraSure to offer its OraQuick® HIV Self-Test at an affordable price in 50 developing countries with funding from the Gates Foundation. The funding will consist of support payments tied to the volume of product sold by OraSure and reimbursement of certain related costs.

Read the press release here.